Form 4: Director Acquires Quest Diagnostics Stock

Director Timothy M. Ring acquired 1,142 shares of Quest Diagnostics common stock through an award of restricted stock units.

Summary

• Timothy M. Ring, a Director at Quest Diagnostics, acquired 1,142 shares of common stock on May 20, 2026.
• These shares were acquired as an award of restricted stock units.
• Following this transaction, Mr. Ring beneficially owns 31,140 shares of common stock directly.
• The acquisition also includes shares acquired via dividend reinvestment under the Amended and Restated Deferred Compensation Plan for Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While director stock acquisition can be positive, this specific filing is a routine disclosure of an award and does not indicate new strategic initiatives or significant financial performance changes.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 1,142 shares directly by a director indicates continued investment in the company.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that director stock acquisitions are common filings under Section 16 of the Securities Exchange Act of 1934. These transactions provide transparency into insider investment decisions within the healthcare diagnostics sector.

Stakeholder Impact

• Shareholders: Increased transparency into director's holdings and potential confidence signal.
• Management: Routine disclosure of compensation-related stock awards.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership